bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Lineage Cell Therapeutics Inc. logo

    Lineage Cell Therapeutics Inc.

    LCTX | AMEX
    Chart Builder DCF Calculator
    $1.01
    -$0.02 (-1.94%)
    At close: Sep 21, 2026, 4:00 PM ET
    $1.04
    +$0.03 (+2.97%)
    Pre-market: Sep 22, 2026, 5:19 AM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $251.79M
    Enterprise Value
    $203.26M
    Beta
    1.55
    Average Volume
    1.33M
    Shares Outstanding (Diluted)
    261.47M
    Shares Change YoY
    14.5%
    Institutional Ownership
    45.58%
    Exchange
    AMEX
    ISIN
    US53566P1093

    Price Performance

    Price Change 1M
    -7.3%
    Price Change 3M
    -19.2%
    Price Change 6M
    -34.8%
    Price Change YTD
    -38.4%
    Price Change 1Y
    -37.6%
    Price Change 3Y
    -15.1%
    Price Change 5Y
    -60.7%
    1M CAGR (ann.)
    -8.2%
    1Y CAGR (ann.)
    -34.8%
    5Y CAGR (ann.)
    -15.3%
    All-Time CAGR
    8.2%

    Valuation

    PE Ratio
    -5.61
    Forward PE
    N/A
    PEG Ratio
    0.18
    Forward PEG
    -0.13
    PS Ratio
    19.25
    Forward PS
    29.10
    PB Ratio
    4.21
    P/FCF Ratio
    -10.52
    P/Adj. FCF Ratio
    -8.68
    P/OCF Ratio
    -10.10
    EV/Sales
    15.54
    EV/EBIT
    -5.44
    EV/EBITDA
    -5.52
    EV/FCF
    -8.49
    Earnings Yield
    -17.8%
    FCF Yield
    -9.5%
    Adj. FCF Yield
    -11.5%

    Financial Health

    Net Cash
    $48.53M
    Total Debt
    $2.3M
    Cash & Short-Term Investments
    $50.83M
    Total Assets
    $106.22M
    Current Ratio
    6.61
    Quick Ratio
    6.61
    Debt / Equity Ratio
    0.04
    Debt / EBITDA
    -0.06
    Debt / FCF
    -0.10
    OCF / Debt
    -10.36
    Interest Coverage
    0.00
    Altman Z-Score
    -3.48
    Piotroski F-Score
    5

    Margins & Profitability

    Gross Profit Margin
    96.6%
    Operating Profit Margin
    -205.2%
    EBITDA Margin
    -280.1%
    Net Profit Margin
    -246.6%
    FCF Margin
    -183.0%
    Adj. FCF Margin
    -221.7%
    SBC / Revenue
    38.8%
    SBC Impact (per share)
    -21.2%

    Returns

    Return on Assets
    -30.4%
    Return on Equity
    -71.1%
    Return on Invested Capital
    -23.3%
    Return on Capital Employed
    -27.3%
    Return on Tangible Assets
    -50.5%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    7.5%
    Revenue CAGR 5Y
    60.1%
    Revenue CAGR 10Y
    18.1%
    EPS CAGR 3Y
    -15.3%
    EPS CAGR 5Y
    12.2%
    EPS CAGR 10Y
    -15.1%
    FCF CAGR 3Y
    -3.5%
    FCF CAGR 5Y
    -23.8%
    FCF CAGR 10Y
    5.9%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    3
    EPS Growth Next 3Y
    83.3%
    Revenue Growth Next 3Y
    111.3%
    Earnings Date
    Nov 4, 2026
    EPS Estimate (next Q)
    -$0.03
    EPS Growth Est (next Q)
    -76.9%
    Revenue Est (next Q)
    $1.28M
    Revenue Growth Est (next Q)
    -65.2%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $5.33
    Price Target Upside
    427.7%

    Cash Flow

    Operating Cash Flow
    $-23.82M
    Free Cash Flow
    $-23.94M
    Adj. Free Cash Flow
    $-29.01M
    FCF Per Share
    -$0.10
    OCF Per Share
    -$0.10
    OCF/S Ratio
    -182.0%

    Income Statement

    Revenue
    $13.08M
    Gross Profit
    $12.82M
    Operating Income
    $-26.85M
    EBITDA
    $-36.83M
    Net Income
    $-32.26M
    EPS (Diluted)
    -$0.18
    Revenue / Employee
    $174.44K
    Profit / Employee
    $-430.13K
    Employees
    75

    © 2026 bestshares.com. All rights reserved.